Institutional investors purchased a net $1.4 million shares of SCMP during the quarter ended March 2017. This may signal that the smart money is gaining interest in this company as the 56.68% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Major industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BLACKROCK FUND ADVISORS Bought 1.3 Million shares of Sucampo Pharmaceuticals I...